DB:25E

Stock Analysis Report

Executive Summary

Elan Corporation provides nursing care services to individual and corporate customers in Japan.

Snowflake

Fundamentals

Flawless balance sheet with high growth potential.

Share Price & News

How has Elan's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-1.4%

25E

-0.2%

DE Healthcare

1.7%

DE Market


1 Year Return

23.7%

25E

-20.7%

DE Healthcare

7.2%

DE Market

Return vs Industry: 25E exceeded the German Healthcare industry which returned -20.7% over the past year.

Return vs Market: 25E exceeded the German Market which returned 7.2% over the past year.


Shareholder returns

25EIndustryMarket
7 Day-1.4%-0.2%1.7%
30 Day-7.0%-3.8%2.4%
90 Day-2.8%-8.3%2.3%
1 Year24.1%23.7%-19.3%-20.7%10.6%7.2%
3 Year380.5%371.8%-28.9%-31.5%18.4%8.1%
5 Yearn/a13.3%7.0%42.3%22.9%

Price Volatility Vs. Market

How volatile is Elan's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Elan undervalued compared to its fair value and its price relative to the market?

53.65x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 25E (€13.6) is trading above our estimate of fair value (€4.71)

Significantly Below Fair Value: 25E is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 25E is poor value based on its PE Ratio (53.6x) compared to the Healthcare industry average (27.9x).

PE vs Market: 25E is poor value based on its PE Ratio (53.6x) compared to the German market (19x).


Price to Earnings Growth Ratio

PEG Ratio: 25E is poor value based on its PEG Ratio (2.4x)


Price to Book Ratio

PB vs Industry: 25E is overvalued based on its PB Ratio (11.1x) compared to the DE Healthcare industry average (1.4x).


Next Steps

Future Growth

How is Elan forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

22.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 25E's forecast earnings growth (22.4% per year) is above the savings rate (0.2%).

Earnings vs Market: 25E's earnings (22.4% per year) are forecast to grow faster than the German market (12.7% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 25E's revenue (16.6% per year) is forecast to grow faster than the German market (5% per year).

High Growth Revenue: 25E's revenue (16.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 25E's Return on Equity is forecast to be high in 3 years time (22.1%)


Next Steps

Past Performance

How has Elan performed over the past 5 years?

23.3%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if 25E's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare 25E's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.

Earnings vs Industry: 25E earnings growth over the past year (23.3%) exceeded the Healthcare industry 12.6%.


Return on Equity

High ROE: 25E's Return on Equity (20.7%) is considered high.


Return on Assets

ROA vs Industry: 25E has a higher Return on Assets than the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: Insufficient data to calculate 25E's Return on Capital Employed to determine if it has improved over the past 3 years.


Next Steps

Financial Health

How is Elan's financial position?


Financial Position Analysis

Short Term Liabilities: 25E's short term assets (¥7.2B) exceeds its short term liabilities (¥3.5B)

Long Term Liabilities: 25E's short term assets (7.2B) exceeds its long term liabilities (6.0M)


Debt to Equity History and Analysis

Debt Level: 25E is debt free.

Reducing Debt: 25E has not had any debt for past 5 years.

Debt Coverage: 25E has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 25E has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: 25E has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if 25E's debt is covered by short term assets.


Next Steps

Dividend

What is Elan's current dividend yield, its reliability and sustainability?

0.53%

Current Dividend Yield


Upcoming Dividend Payment

Purchase Elan before the 'Buy Limit' to receive their next dividend payment.


Dividend Yield vs Market

company0.5%marketbottom25%1.5%markettop25%3.8%industryaverage2.0%forecastin3Years0.6%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: 25E's dividend (0.53%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.48%).

High Dividend: 25E's dividend (0.53%) is low compared to the top 25% of dividend payers in the German market (3.83%).

Stable Dividend: 25E is not paying a notable dividend for the German market, therefore no need to check if payments are stable.

Growing Dividend: 25E is not paying a notable dividend for the German market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: 25E is not paying a notable dividend for the German market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 25E's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

What is the CEO of Elan's salary, the management and board of directors tenure and is there insider trading?

3.1yrs

Average management tenure


CEO

Eiji Sakurai (49yo)

0yrs

Tenure

0

Mr. Eiji Sakurai serves as the President at Elan Corporation and has been its General Manager of Sales Division since October 2016. Mr. Sakurai established Elan Corporation in February 1995. He Joined Peop ...


Management Age and Tenure

3.1yrs

Average Tenure

49.5yo

Average Age

Experienced Management: 25E's management team is considered experienced (3.1 years average tenure).


Board Age and Tenure

5.6yrs

Average Tenure

53yo

Average Age

Experienced Board: 25E's board of directors are considered experienced (5.6 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Nobuhiro Nakajima (50yo)

    Senior MD

    • Tenure: 0yrs
  • Eiji Sakurai (49yo)

    President

    • Tenure: 0yrs
  • Tomohiro Minesaki (47yo)

    Deputy GM of Sales Division & Director

    • Tenure: 8.3yrs
  • Atsushi Watanabe (47yo)

    CFO & Director

    • Tenure: 5.4yrs
  • Yoshiteru Ando (72yo)

    VP & Director

    • Tenure: 4.6yrs
  • Hideo Hara (56yo)

    GM of Administration Division

    • Tenure: 0yrs

Board Members

  • Nobuyuki Takagi (66yo)

    External Auditor

    • Tenure: 6.3yrs
  • Nobuhiro Nakajima (50yo)

    Senior MD

    • Tenure: 0yrs
  • Eiji Sakurai (49yo)

    President

    • Tenure: 0yrs
  • Tomohiro Minesaki (47yo)

    Deputy GM of Sales Division & Director

    • Tenure: 8.3yrs
  • Atsushi Watanabe (47yo)

    CFO & Director

    • Tenure: 5.4yrs
  • Yoshiteru Ando (72yo)

    VP & Director

    • Tenure: 4.6yrs
  • Kenji Hayashi (67yo)

    Standing Corporate Auditor

    • Tenure: 5.6yrs
  • Naohide Aikawa (42yo)

    External Auditor

    • Tenure: 5.6yrs
  • Hideo Hara (56yo)

    GM of Administration Division

    • Tenure: 0yrs
  • Koji Fujita (66yo)

    External Director

    • Tenure: 0yrs

Company Information

Elan Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Elan Corporation
  • Ticker: 25E
  • Exchange: DB
  • Founded: 1995
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: JP¥51.146b
  • Listing Market Cap: JP¥423.299m
  • Shares outstanding: 30.30m
  • Website: https://www.kkelan.com

Number of Employees


Location

  • Elan Corporation
  • 15-12 Degawa-machi
  • Matsumoto
  • Nagano
  • 390-0826
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
6099TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYNov 2014
25EDB (Deutsche Boerse AG)YesCommon StockDEEURNov 2014

Biography

Elan Corporation provides nursing care services to individual and corporate customers in Japan. The company engages in the long-term medical care related business. It offers CS set, a combined rental servi ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/23 21:41
End of Day Share Price2019/10/23 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.